ten children with transfusion dependent anemias ( thalassemia , sideroblastic anemia , congenital pure red cell aplasia ) received either intravenous desferrioxamine ( df ) in increasing doses up to 450 mg/kg at the time of transfusion or daily subcutaneous df up to 110 mg/kg on an outpatient basis .
C0002871
anemias
C0002896
sideroblastic